Dr. Kathleen K. Harnden
Claim this profileInova Schar Cancer Institute
Studies Breast Cancer
Studies Cancer
7 reported clinical trials
22 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage III
HER2 negative
2Cancer
Stage IV
Stage III
NTRK positive
Affiliated Hospitals
Clinical Trials Kathleen K. Harnden is currently running
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial. The phase 1b part of the trial aims to determine the RP2D of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, abemaciclib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in patients with ER+/HER2- advanced/metastatic breast cancer.
Recruiting1 award Phase 1 & 2
Targeted Therapy
for Brain Cancer
This phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK, ROS1, CDK, PI3K, or KRAS G12C. Medications that target these genes such as abemaciclib, paxalisib, entrectinib and adagrasib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Genetic testing may help doctors tailor treatment for each mutation.
Recruiting1 award Phase 217 criteria
More about Kathleen K. Harnden
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kathleen K. Harnden has experience with
- Alpelisib
- Everolimus
- Trastuzumab
- Pertuzumab
- Abemaciclib
- Crofelemer
Breakdown of trials Kathleen K. Harnden has run
Breast Cancer
Cancer
Prevention of Diarrhea
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathleen K. Harnden specialize in?
Kathleen K. Harnden focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kathleen K. Harnden currently recruiting for clinical trials?
Yes, Kathleen K. Harnden is currently recruiting for 3 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that Kathleen K. Harnden has studied deeply?
Yes, Kathleen K. Harnden has studied treatments such as Alpelisib, Everolimus, Trastuzumab.
What is the best way to schedule an appointment with Kathleen K. Harnden?
Apply for one of the trials that Kathleen K. Harnden is conducting.
What is the office address of Kathleen K. Harnden?
The office of Kathleen K. Harnden is located at: Inova Schar Cancer Institute, Fairfax, Virginia 22031 United States. This is the address for their practice at the Inova Schar Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.